Target Name: USHBP1
NCBI ID: G83878
Review Report on USHBP1 Target / Biomarker Content of Review Report on USHBP1 Target / Biomarker
USHBP1
Other Name(s): Usher syndrome 1C binding protein 1 | AIE-75-binding protein | USH1 protein network component harmonin binding protein 1 | MCC-2 | MCC2 | Mutated in colon cancer protein 2 | AIEBP | Harmonin-binding protein USHBP1 | USHBP1 variant 1 | usher syndrome type-1C protein-binding protein 1 | mutated in colon cancer protein 2 | Usher syndrome type-1C protein-binding protein 1 (isoform 1) | USH1 protein network component harmonin binding protein 1, transcript variant 1 | USH1C-binding protein 1 | USBP1_HUMAN | AIE-75 binding protein protein

USHBP1: Potential Drug Targets for Usher Syndrome Type 1

Usher syndrome is a rare genetic disorder that is characterized by a range of developmental and cognitive disabilities. The most common form of the disorder is Usher syndrome type 1, which is caused by a deficiency of dystrophin, a protein that helps keep the cells of the body functioning. In addition to the effects of the deficiency on the cells,Usher syndrome type 1 is also characterized by a range of visual and hearing impairments, as well as cognitive impairments.

The protein USHBP1 is a potential drug target or biomarker for Usher syndrome type 1. USHBP1 is a protein that is expressed in the retina, and it is known to be involved in the development and maintenance of the retina's neural stem cells. Studies have shown that USHBP1 plays a role in the regulation of cell proliferation and differentiation, and that it is involved in the development of neurodegeneration.

One of the key features of USHBP1 is its ability to interact with the protein USHBP2, which is also known as the retinal stem cell factor (RSF). USHBP2 is a protein that is expressed in the retina and is involved in the regulation of cell proliferation and differentiation. Studies have shown that USHBP1 and USHBP2 can interact with each other and that this interaction is involved in the development and maintenance of the retina's neural stem cells.

In addition to its role in the regulation of neural stem cells, USHBP1 is also involved in the regulation of cell survival. Studies have shown that USHBP1 plays a role in the regulation of cell survival by promoting the production of a protein called Bcl-2. Bcl-2 is a protein that is involved in cell survival and it is thought to be involved in the development of neurodegeneration.

Another feature of USHBP1 is its ability to interact with the protein p53. p53 is a protein that is involved in the regulation of cell growth and it is thought to be involved in the development of neurodegeneration. Studies have shown that USHBP1 and p53 can interact with each other and that this interaction is involved in the regulation of cell growth and survival.

In conclusion, USHBP1 is a protein that is involved in the regulation of cell proliferation and differentiation, as well as cell survival. Studies have shown that USHBP1 plays a role in the development and maintenance of the retina's neural stem cells, and that it is involved in the regulation of neural stem cell proliferation and differentiation. Additionally, USHBP1 is also known to interact with the protein USHBP2 and p53, which may be potential drug targets or biomarkers for Usher syndrome type 1.

Protein Name: USH1 Protein Network Component Harmonin Binding Protein 1

The "USHBP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about USHBP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

USO1 | USP1 | USP1-UAF1 complex | USP10 | USP11 | USP12 | USP12-AS1 | USP12-DT | USP13 | USP14 | USP15 | USP16 | USP17L1 | USP17L10 | USP17L11 | USP17L12 | USP17L13 | USP17L14P | USP17L15 | USP17L17 | USP17L18 | USP17L2 | USP17L20 | USP17L21 | USP17L24 | USP17L25 | USP17L26 | USP17L27 | USP17L29 | USP17L3 | USP17L5 | USP17L6P | USP17L7 | USP17L8 | USP17L9P | USP18 | USP19 | USP2 | USP2-AS1 | USP20 | USP21 | USP22 | USP24 | USP25 | USP26 | USP27X | USP27X-DT | USP28 | USP29 | USP3 | USP3-AS1 | USP30 | USP30-AS1 | USP31 | USP32 | USP32P1 | USP32P2 | USP32P3 | USP33 | USP34 | USP35 | USP36 | USP37 | USP38 | USP39 | USP4 | USP40 | USP41 | USP42 | USP43 | USP44 | USP45 | USP46 | USP46-DT | USP47 | USP48 | USP49 | USP5 | USP50 | USP51 | USP53 | USP54 | USP6 | USP6NL | USP6NL intronic transcript 1 (non-protein coding), transcript variant 1 | USP7 | USP8 | USP8P1 | USP9X | USP9Y | USPL1 | UST | UTF1 | UTP11 | UTP14A | UTP14C | UTP15 | UTP18 | UTP20 | UTP23